ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Leidos Biomedical Research, INC.

Official 2024 U.S. DOL Form 5500 summary for Leidos Biomedical Research, INC. (Leidos Biomedical Research, INC. Capital Accumulation Plan · EIN 33-0653185 · PN 003): $366.16M net assets, 2,319 active participants, and $3.10 per $10,000 (3.10 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorLeidos Biomedical Research, INC.
Filing IdentifierLeidos Biomedical Research, INC. Capital Accumulation Plan · EIN 33-0653185 · PN 003
Plan Category & State401(k) Defined Contribution (MD)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$366.16M
Active Participants2,319
Direct Admin Fee Rate$3.10 per $10,000 (3.10 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderVanguard
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI